In vivo editing studies have been explored in genetic muscular diseases, for example, Duchenne muscular dystrophy (DMD), characterized by progressive muscle weakness and premature death due to mutation in the dystrophin gene. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.